Relation of Plasma Xanthine Oxidoreductase Activity to Coronary Lipid Core Plaques Assessed by Near-Infrared Spectroscopy Intravascular Ultrasound in Patients With Stable Coronary Artery Disease.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 01 11 2019
revised: 19 12 2019
accepted: 23 12 2019
pubmed: 21 1 2020
medline: 26 6 2020
entrez: 21 1 2020
Statut: ppublish

Résumé

Previous studies reported that elevated serum uric acid level was associated with greater coronary lipid plaque. Xanthine oxidoreductase (XOR) is a rate-limiting enzyme in purine metabolism and is believed to play important roles in coronary atherosclerosis. However, the relation between XOR and coronary lipid plaque is unclear. Patients with stable coronary artery disease who underwent elective percutaneous coronary intervention under near-infrared spectroscopy intravascular ultrasound (NIRS-IVUS) guidance were prospectively included. They were divided into 3 groups according to plasma XOR activities based on a previous report: low, normal, and high. Quantitative coronary angiography and gray-scale IVUS were analyzed. The primary end point was coronary lipid plaques in a nontarget vessel assessed by NIRS-IVUS with lipid core burden index (LCBI) and maximum LCBI in 4 mm (maxLCBI

Identifiants

pubmed: 31955828
pii: S0002-9149(20)30010-2
doi: 10.1016/j.amjcard.2019.12.043
pii:
doi:

Substances chimiques

Biomarkers 0
Lipids 0
Xanthine Dehydrogenase EC 1.17.1.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1006-1012

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Naoto Mori (N)

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan. Electronic address: polymol.3321@gmail.com.

Yuichi Saito (Y)

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan; Yale University School of Medicine, New Haven, Connecticut.

Kan Saito (K)

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Takaaki Matsuoka (T)

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Kazuya Tateishi (K)

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Tadayuki Kadohira (T)

Department of Cardiology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.

Hideki Kitahara (H)

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Yoshihide Fujimoto (Y)

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Yoshio Kobayashi (Y)

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH